2019 Conference on Retroviruses and Opportunistic Infections

March 4-7, 2019; Seattle, Washington
Get up to date on the latest HIV data with rapid Capsule Summaries, downloadable slidesets, and expert analysis covering key studies from Seattle.

Share

Program Content

10 Capsule Summary Slidesets

Activities

NICHD P1081
NICHD P1081: Improved Virologic Suppression at Delivery With RAL- vs EFV-Based ART in Pregnant Women With HIV Infection
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 07, 2019

Expires: March 05, 2020

DolPHIN-2
DolPHIN-2: More Rapid Virologic Suppression With DTG- vs EFV-Based ART Initiated in Late Pregnancy
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 08, 2019

Expires: March 06, 2020

ATLAS
ATLAS: Week 48 Results From Phase III Study of Switching to Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Patients With No Prior Virologic Failure
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 09, 2019

Expires: March 07, 2020

Opioid Overdose Deaths in HIV
Increased Deaths From Opioid Overdose Among Persons With HIV Infection, 2011-2015
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2019

Expires: March 09, 2020

DISCOVER
DISCOVER: Phase III Study of Emtricitabine/Tenofovir Alafenamide vs Emtricitabine/Tenofovir Disoproxil Fumarate for HIV PrEP
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2019

Expires: March 09, 2020

PrEP and Drug Resistance
Effects of PrEP on Drug Resistance and Acute HIV Infection in New York City Surveillance Population
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2019

Expires: March 09, 2020

FLAIR
FLAIR: Switch to Long-Acting CAB + RPV Following Oral Induction in ART-Naive Patients Noninferior to Continued DTG/ABC/3TC at Week 48
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2019

Expires: March 09, 2020

HPTN 077
HPTN 077: No Significant Weight Gain at Week 41 With Long-Acting CAB vs PBO in HIV-Uninfected Persons at Low Risk for Infection
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2019

Expires: March 09, 2020

Study 380-1474
GS-US-380-1474: Switch to BIC/FTC/TAF Safely Maintains Virologic Suppression at Week 48 in Children and Adolescents With HIV Infection
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2019

Expires: March 09, 2020

DAWNING
DAWNING: High Virologic Response Rates at Week 48 With DTG-Based ART Regardless of Baseline NRTI RAMs and Second-Line NRTI Use
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 13, 2019

Expires: March 11, 2020

Activities

CROI Hot Topics
Preview of Hot Topics at CROI 2019: My Picks
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2019

Expires: February 28, 2020

New Data From CROI 2019
Clinical Impact of New HIV Data From CROI 2019
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2019

Expires: March 20, 2020

Long-Acting Injectable ART
A New Chapter in ART? Implications of ATLAS and FLAIR Results From CROI 2019
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: May 10, 2019

Expires: May 08, 2020

Activities

DISCOVER Data From CROI
CROI 2019: Results From the DISCOVER Trial and Implications for HIV PrEP in Germany
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: April 05, 2019

Expires: April 03, 2020

ART and Weight From CROI
My Perspective: What CROI 2019 ART and Weight Gain Data Mean for Spain
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: May 02, 2019

Expires: April 30, 2020

HCV, HIV, and Pregnancy
HCV in HIV and Pregnancy: UK Clinical Challenges and New CROI 2019 Data
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: May 09, 2019

Expires: May 07, 2020

CROI: INSTIs in Pregnancy
CROI 2019 Results From 2 Randomized Trials Evaluating INSTI-Based ART Initiation During Pregnancy: Implications for HIV Care in France
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 18, 2019

Expires: July 16, 2020

Faculty

cover img faculity

W. David Hardy, MD

Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

cover img faculity

Esteban Martínez, MD, PhD

Team Leader Consultant & Associate Professor of Medicine
Infectious Diseases Unit
Hospital Clinic of Barcelona
University of Barcelona
Barcelona, Spain

cover img faculity

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities 
Dean for Healthcare Transformation
Queen Mary University of London
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom

cover img faculity

Jürgen Rockstroh, MD

Professor of Medicine
Head of Infectious Diseases
Department of Medicine I
University Hospital Bonn
Bonn, Germany

cover img faculity

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Provided by

ProCE Banner

Supporters

This program is supported by independent educational grants from

Gilead

Gilead Text

Janssen

Merck Human Health HIV

ViiV Healthcare